Jiri Neuzil • Shazib Pervaiz • Simone Fulda
Editors

2014

The onset of the third millennium has witnessed unprecedented progress in molecular medicine. Despite this fact, a number of pathologies remain an overwhelming burden that is yet to be fully understood and, consequently, harnessed. This applies for some of the most widespread and hard-to-manage pathologies, epitomized in particular by neoplastic and neurodegenerative as well as cardiovascular diseases. Therefore, new approaches and new targets are needed to progress in the fight against these debilitating ailments.